2016
DOI: 10.1177/0268355515610237
|View full text |Cite
|
Sign up to set email alerts
|

Dysregulated apoptosis of the venous wall in chronic venous disease and portal hypertension

Abstract: Introduction The etiology of varicose veins remains elusive. We hypothesized that abnormal cell cycle events in the vein wall may contribute to changes in the structural integrity, thus predisposing to the development of varicosities. The present study was designed to determine whether or not the same molecular apoptotic pathway exists between great saphenous and splenic veins. Methods Thirty-six samples of diseased splenic veins and varicose great saphenous veins were collected. Twenty-five samples of control… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0
2

Year Published

2016
2016
2022
2022

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 16 publications
(8 citation statements)
references
References 39 publications
0
6
0
2
Order By: Relevance
“…Increased presence of apoptotic endothelial and smooth muscle cells was documented in varicose veins removed from older patients [40]. Recent observations confirmed the presence of apoptotic cells in the venous wall in chronic venous insufficiency [237].…”
Section: Increased Vascular Apoptosismentioning
confidence: 76%
“…Increased presence of apoptotic endothelial and smooth muscle cells was documented in varicose veins removed from older patients [40]. Recent observations confirmed the presence of apoptotic cells in the venous wall in chronic venous insufficiency [237].…”
Section: Increased Vascular Apoptosismentioning
confidence: 76%
“…In vessels, immature vascular smooth muscle cells (VSMCs) are prone to proliferation, migration and synthesis of ECM components (5). The apoptotic decrease of portal vein smooth muscle cells (PVSMCs) in the vein wall is a cause of portal vein remodeling in PHT (6). Currently, there are no approved therapeutic options designed to reverse the progression of PHT.…”
Section: Introductionmentioning
confidence: 99%
“…Как и многие другие процессы в венозной стенке, это событие имеет как молекулярные, так и генетические причины. Среди них гиперэкспрессия антиапоптотического гена BCL2, что вызывает изменение баланса между индукторами и ингибиторами апоптоза [30][31][32]. Секреция BCL2 может усиливаться при гипоксии стенки вены из-за ее перерастяжения и сдавления vasa vasorum [31,33].…”
Section: Review научный обзорunclassified